Investor relations

Investor relations

AstraZeneca appoints Citibank, N.A. as depositary bank for its U.S. American Depositary Receipt (ADR) Programme

6 February 2015

Download further information (PDF 27kb)

Fourth quarter and full year results 2014

5 February 2015

AstraZeneca announced fourth quarter and full year results for 2014 on Thursday 5th February 2015. Presentations were made by Pascal Soriot, Chief Executive Officer; Marc Dunoyer, Chief Financial Officer; Briggs Morrison, EVP Global Medicines Development and Luke Miels EVP GPPS.

View event details


Latest downloads

Fourth quarter and full year results 2014

5 February 2015

33rd J.P. Morgan Healthcare Conference, San Francisco

14 January 2015

Accounting for the US Branded Pharmaceutical Fee

7 January 2015

AstraZeneca Investor Day

18 November 2014

Third quarter and nine months results 2014

6 November 2014


Share price

London
44.24 GBP
New York
67.79 USD
Stockholm
564.00 SEK

At 5-3-2015 06:25 GMT

Detailed share price


Stock symbol - AZN

On LSE, NYE and OMX